Skip to content

Maintaining Oral Health With Bio-products

Maintaining Oral Health With Bio-products: a Randomized, Cross-over, in Situ Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04033263
Enrollment
12
Registered
2019-07-26
Start date
2024-11-01
Completion date
2025-06-30
Last updated
2025-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Caries, Dental Erosion

Brief summary

This study will follow a randomised, double-blind, cross-over design. Participants will use mouth rinses containing plant extracts and/or fluoride, as well as a mouth rinse containing only water (placebo). They will use oral appliances containing sterilized enamel and dentine slabs, which will be later collected for analyses. The cross-over design will allow participants to use all rinses, allowing for a comparison between the rinses within each individual.

Detailed description

This study will be made in three in situ parts. Participants will wear an oral appliance containing sterilized enamel and dentine slabs. During this experimental phase, they will use the designated mouth rinse. After this period, the investigators will remove the enamel and dentine slabs, and will also collect salivary pellicle and any bacterial biofilm forming on the participant's teeth. Participants will also donate saliva for proteomic analysis (protein profile) to verify if there are any differences in proteins in saliva to proteins in the pellicle. Throughout the whole study, all participants will use standardized oral hygiene products. The experimental mouth rinses contain plant extracts that could interact with salivary proteins and influence the salivary pellicle and oral biofilm, thus bringing positive results against tooth (enamel and dentine) demineralisation.

Interventions

Participants will use 10mL of the respective mouth rinse, swish in the mouth for 30 seconds and spit it out. This will be made twice a day, for a total of 5 days.

Participants will use 10mL of the respective mouth rinse, swish in the mouth for 30 seconds and spit it out. This will be made twice a day, for a total of 5 days.

Participants will use 10mL of the respective mouth rinse, swish in the mouth for 30 seconds and spit it out. This will be made twice a day, for a total of 5 days.

OTHERMouth rinse 4

Participants will use 10mL of the respective mouth rinse, swish in the mouth for 30 seconds and spit it out. This will be made twice a day, for a total of 5 days.

Sponsors

University of Bern
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Caregiver)

Masking description

Mouth rinses will be placed in coded bottles, and the investigator and patients will not know to which group they belong. This is a cross-over study, where all 12 participants will use all 4 rinses.

Intervention model description

Cross-over study, where all participants will use all treatments. The treatment order will be set at random.

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Participants will be healthy young adults of both sexes, with normal salivary flow, with no cavitated caries lesions, no gingivitis or periodontal disease, no severe erosive tooth wear, and no other serious general or oral conditions. * Participants will have signed an informed consent form.

Exclusion criteria

* Presenting oral diseases or conditions, such as untreated cavitated caries lesions, gingivitis or periodontitis, severe erosive tooth wear, etc. * Participants who are under orthodontic treatment (wearing braces), * Contraindications to the mouth rinses under study, e.g. known hypersensitivity or allergy to the investigational product, * Participants using drugs that cause hyposalivation, * Women who are pregnant or breast feeding, * Intention to become pregnant during the course of the study, * Individuals suffering from clinically significant concomitant disease states (e.g., renal failure, hepatic dysfunction, cardiovascular disease, etc.), * Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant, * Participation in another study with investigational drug within the 30 days preceding and during the present study, * Enrolment of the investigator, his/her family members, employees and other dependent persons, * Specific exclusions for the disease under study, * Specific concomitant therapy washout requirements prior to and/or during study participation

Design outcomes

Primary

MeasureTime frameDescription
Enamel mineral lossEnd of the study arm, expected to be after 1 week of using the mouth rinseHardness of enamel slabs (Knoop hardness)
Dentine mineral lossEnd of the study arm, expected to be after 1 week of using the mouth rinseProfilometry of dentine specimens (step height in µm)

Secondary

MeasureTime frameDescription
Thickness of the salivary pellicleEnd of the study arm, expected to be after 1 week of using the mouth rinseMeasured using TEM (mineralization measured in Delta Z)
pH of the participants' biofilmEnd of the study arm in part 3, expected to be after 1 day of using the mouth rinseMeasured in vivo after using the mouth rinses (pH)
Identification of which proteins are present in the participants' salivaEnd of the study arm, expected to be after 1 week of using the mouth rinseProteomic analyses of the saliva (list of proteins present)
How many bacteria are adhered to the biofilmEnd of the study arm in part 3, expected to be after 1 day of using the mouth rinseMeasured after collecting the biofilm (bacteria quantity)
Identification of the bacteria in the biofilmEnd of the study arm in part 3, expected to be after 1 day of using the mouth rinseMeasured after collecting the biofilm (list of bacterial species)
Identification of which proteins are present in the participants' salivary pellicleEnd of the study arm, expected to be after 1 week of using the mouth rinseProteomic analyses of the salivary pellicle (list of proteins present)

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 5, 2026